alpha-naphthoflavone has been researched along with quercetin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobson, KA; Ji, XD; Melman, N | 1 |
| Jacobson, KA; Moro, S; Sanders, LH; van Rhee, AM | 1 |
| Strassburg, CP; Tukey, RH | 1 |
| Blank, VC; Marder, M; Poli, C; Roguin, LP | 1 |
| Hashizume, H; Kawasaki, M; Komatsu, M; Matsumoto, M; Sasaki, H; Shimokawa, Y; Tomishige, T; Tsubouchi, H | 1 |
| Muftuoglu, Y; Mustata, G | 1 |
| Bharate, SB; Chaudhuri, B; Gatchie, L; Horley, N; Jayaprakash, V; Joshi, P; McCann, GJ; Mohd Siddique, MU; Sinha, BN; Sonawane, VR | 1 |
| Dutour, R; Poirier, D | 1 |
| Chen, Y; Dong, R; Hou, S; Huang, J; Li, H; Liu, C; Liu, X; Lu, T; Tang, W; Wang, X; Xu, J; Zhang, T; Zhang, Y | 1 |
| Mizusaki, S; Okamoto, H; Yoshida, D | 1 |
| Calvo, DJ; Doñate-Oliver, F; Goutman, JD; Pomata, PE; Waxemberg, MD | 1 |
| Dong, MS; Kang, IH; Kim, HJ; Oh, H; Park, YI | 1 |
| Hu, H; Lou, Y; Qiu, Y; Wang, L; Zeng, S; Zhang, X; Zheng, J | 1 |
2 review(s) available for alpha-naphthoflavone and quercetin
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
Inhibitors of cytochrome P450 (CYP) 1B1.
Topics: Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Structure-Activity Relationship | 2017 |
11 other study(ies) available for alpha-naphthoflavone and quercetin
| Article | Year |
|---|---|
Interactions of flavonoids and other phytochemicals with adenosine receptors.
Topics: Animals; Cell Line; CHO Cells; Cricetinae; Flavonoids; Humans; Magnetic Resonance Spectroscopy; Plants; Protein Binding; Radioligand Assay; Rats; Receptors, Purinergic P1 | 1996 |
Flavonoid derivatives as adenosine receptor antagonists: a comparison of the hypothetical receptor binding site based on a comparative molecular field analysis model.
Topics: Binding Sites; Computer Simulation; Flavonoids; Kinetics; Least-Squares Analysis; Models, Molecular; Molecular Conformation; Molecular Structure; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A3; Receptors, Purinergic P1; Regression Analysis; Reproducibility of Results; Static Electricity; Structure-Activity Relationship | 1998 |
Antiproliferative activity of various flavonoids and related compounds: additive effect of interferon-alpha2b.
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Synergism; Flavonoids; Growth Inhibitors; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins | 2004 |
OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice.
Topics: Animals; Antitubercular Agents; Blood; Cell Line; Humans; In Vitro Techniques; Intracellular Membranes; Macrophages; Mammals; Mice; Microbial Sensitivity Tests; Microsomes, Liver; Mycobacterium; Mycobacterium bovis; Mycolic Acids; Nitroimidazoles; Oxazoles; Treatment Outcome; Tuberculosis | 2006 |
Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19).
Topics: Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Binding Sites; Breast Neoplasms; Computer Simulation; Drug Design; Female; Humans; Models, Chemical; Models, Molecular; Structure-Activity Relationship | 2010 |
Quinazoline derivatives as selective CYP1B1 inhibitors.
Topics: Antineoplastic Agents; Cell Membrane Permeability; Cells, Cultured; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; Cytochrome P450 Family 2; Cytochrome P450 Family 3; Enzyme Inhibitors; Humans; Models, Molecular; Quinazolines; Yeasts | 2017 |
Discovery of
Topics: Administration, Oral; Animals; Antineoplastic Agents; Area Under Curve; Catalytic Domain; Cell Line, Tumor; Cyclin-Dependent Kinase 9; Half-Life; Humans; Mice; Molecular Structure; Protein Binding; Protein Kinase Inhibitors; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2021 |
Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced induction in Epstein-Barr virus early antigen in Raji cells.
Topics: Antigens, Viral; Benzoflavones; beta-Naphthoflavone; Burkitt Lymphoma; Cells, Cultured; Cholic Acid; Cholic Acids; Estradiol; Humans; Hydrocortisone; Phorbols; Quercetin; Rutin; Sweetening Agents; Tetradecanoylphorbol Acetate; Virus Activation; Vitamin A | 1983 |
Flavonoid modulation of ionic currents mediated by GABA(A) and GABA(C) receptors.
Topics: Animals; Apigenin; Benzoflavones; Female; Flavonoids; Humans; Membrane Potentials; Microinjections; Oocytes; Quercetin; Rats; Receptors, GABA; Receptors, GABA-A; Receptors, Neurotransmitter; RNA, Complementary; Xenopus laevis | 2003 |
Biphasic effects of the flavonoids quercetin and naringenin on the metabolic activation of 2-amino-3,5-dimethylimidazo[4,5-f]quinoline by Salmonella typhimurium TA1538 co-expressing human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and cytochrom
Topics: Benzoflavones; Cytochrome P-450 CYP1A2; Cytochromes b5; Flavanones; Humans; Mutagenicity Tests; Mutagens; NADPH-Ferrihemoprotein Reductase; Prodrugs; Quercetin; Quinolines; Salmonella typhimurium | 2004 |
Metabolism of chamaechromone in vitro with human liver microsomes and recombinant human drug-metabolizing enzymes.
Topics: Antiviral Agents; Benzoflavones; Cytochrome P-450 CYP1A2; Drug Interactions; Drugs, Chinese Herbal; Flavones; Fluconazole; Glucuronosyltransferase; Humans; Hydroxylation; In Vitro Techniques; Liver; Microsomes, Liver; Naphthols; Plant Roots; Quercetin; Recombinant Proteins; Thymelaeaceae | 2014 |